BIOTECH Logo

BIOTECH

A biotechnology group offering preclinical services, intein development, and licensing.

BST | BME Growth

Overview

Corporate Details

ISIN(s):
ES0184980003 (+1 more)
LEI:
959800GNYT6ZZEWPEW29
Country:
Spain
Address:
AVDA. DEL DESARROLLO TECNOLOGICO (PARQUE CIENTIFICO TECNOLOGICO AGROINDUSTRIAL) 11, 11591 Jerez de la Frontera

Description

Biotechnology Assets Biat Group is a biotechnology corporate group with a global commercial structure operating through several subsidiaries. Its subsidiary Biobide is a provider of preclinical services, specializing in tailor-made toxicity and efficacy testing using the zebrafish (ZF) animal model. ZIP Solutions develops and promotes a proprietary set of inteins for high-value industrial applications, including gene therapy, immunotherapy, in-vitro diagnostics, smart vaccines (RNA & DNA), and affinity-based protein purification. The Bionatur division manages biotech assets for human and animal health. The group focuses on licensing its platforms and products, conducting preclinical research, and improving recombinant and DNA vaccines through collaborations.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-03-19 14:18
Net Asset Value(s)
English 4.0 KB
2025-03-18 10:30
Net Asset Value(s)
English 4.0 KB
2025-03-17 14:38
Net Asset Value(s)
English 4.0 KB
2025-03-14 10:53
Net Asset Value(s)
English 4.0 KB
2025-03-13 15:33
Net Asset Value(s)
English 4.0 KB
2025-03-12 14:50
Net Asset Value(s)
English 4.1 KB
2025-03-11 15:54
Net Asset Value(s)
English 4.0 KB
2025-03-10 14:35
Net Asset Value(s)
English 4.0 KB
2025-03-07 14:28
Net Asset Value(s)
English 4.0 KB
2025-03-07 09:08
Net Asset Value(s)
English 4.0 KB
2025-03-06 15:30
Net Asset Value(s)
English 4.0 KB
2025-03-06 08:00
Net Asset Value(s)
English 4.0 KB
2025-03-05 14:34
Net Asset Value(s)
English 4.0 KB
2025-03-04 14:40
Net Asset Value(s)
English 4.0 KB
2025-03-03 15:43
Net Asset Value(s)
English 4.0 KB

Automate Your Workflow. Get a real-time feed of all BIOTECH filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOTECH

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIOTECH via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

HALOZYME THERAPEUTICS, INC. Logo
Biopharmaceutical firm licensing technology to convert IV drugs to subcutaneous forms.
United States of America
HALO
HEALIOS K.K. Logo
Clinical-stage biotech developing regenerative medicine and cell-based therapies.
Japan
4593
HeartSciences Inc. Logo
Medical technology company applying AI to electrocardiography for heart disease detection.
United States of America
HSCS
Heartseed株式会社 Logo
Clinical-stage biotech developing regenerative medicine for severe heart failure.
Japan
219A
Herantis Pharma Oyj Logo
A clinical-stage biotech developing therapies for neurodegenerative diseases like Parkinson's.
Finland
HRTIS
Hipower Energy Spolka Akcyjna Logo
Develops and commercializes hydrogen-based solutions and fuel cell technology.
Poland
HPE
HLB bioStep Co.,Ltd. Logo
A non-clinical CRO providing drug development services, specializing in veterinary medicine.
South Korea
278650
HLB PANAGENE Co., LTD. Logo
Specializes in PNA-based molecular diagnostics for oncology and infectious diseases.
South Korea
046210
HLB SCIENCE Inc. Logo
Develops drugs and diagnostics for infectious, immune, and Alzheimer's diseases.
South Korea
343090
Hoth Therapeutics, Inc. Logo
A clinical-stage biopharma company advancing drugs for unmet medical needs.
United States of America
HOTH

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.